Research and development daily, Hengrui medicine, capecitabine tablet, ever commented that MSD insomnia therapy was approved

The novel coronavirus pneumonia inhibitor JAK1 was approved by SHR0302, the first PDE5 inhibitor of pulmonary hypertension was approved; JAMA revealed the characteristics of the disease in new coronavirus pneumonia infants; the new targeted therapy for endometrial cancer is expected to be developed We focus on the latest development of pharmaceutical research and development, and provide timely and accurate information reference for R & D personnel Today, Hengrui pharmaceutical announced that the company's capecitabine tablets (0.5g) passed the quality and efficacy evaluation of generic drugs Hengrui pharmaceutical announced that its subsidiary, Ruishi biomedical, recently received the notice of clinical trial of shr0302 tablets approved and issued by the State Drug Administration On February 15, the clinical application of ibi362 for injection declared by Cinda biology was accepted by CDE Ibi362 (oxm3) is a potential optimal glucagon like peptide-1 (GLP-1) and glucagon receptor double agonist in the middle stage of clinical development Pfizer announced recently that revanto has been approved by nmpa on February 5, 2020 to treat adult pulmonary hypertension, so as to improve exercise ability and delay clinical deterioration Recently, Haizheng pharmaceutical's fabiravir tablet was officially approved by the State Food and Drug Administration for drug registration Indications for the treatment of new or recurrent influenza in adults That is, the novel coronavirus pneumonia is still expanding in indications Recently, the listing application of "pregabalin capsule" declared by Lu pharmaceutical according to the four categories of new registration classification has completed the technical review and is in the state of "approval", and will be approved for listing After approval, it shall be deemed to pass the conformity assessment MSD announced that FDA approved the update of belsomra's label information, reflecting its clinical data on insomnia symptoms in patients with mild to moderate Alzheimer's disease Novartis announced that the U.S FDA has accepted a new drug application of its met inhibitor capmatinib for the treatment of advanced non-small cell lung cancer patients with mutations in exon 14 of the met gene Recently, Zesheng technology announced that its recombinant human for injection, nuranglin, failed to obtain approval from the State Food and drug administration due to lack of available research data Recently, JAMA published a study from Wuhan University People's Hospital, Wuhan University School of health and other cooperative teams to analyze the epidemiological and clinical characteristics of 9 infants under 1 year old who were infected with new coronavirus In a new study, researchers studied the association between acidosis and jaundice in human samples and animal models, and found that neuron damage increased in samples from newborns with acidosis and jaundice compared to newborns without acidosis Recently, in a research report published in the international journal Cancer Research, researchers from Huntsman Cancer Research Institute revealed the pathogenesis of endometrial cancer through research, and relevant research results may help to develop new anti-cancer therapies Recently, a research report published in the international journal immunology found that T cells in the immune system can communicate with each other and cooperate with each other as a team to play a role In order to resist the infection of the body, they will stimulate each other's growth At the same time, when T cells are surplus, they will inhibit each other Relevant research results may provide researchers with new cancer therapies Ideas and hopes.